VTAMA Cream Performs Well in AD Patients Across the Spectrum of Skin Tones
Tapinarof cream, 1% (Vtama, Dermavant) shows “consistent and high” efficacy in atopic dermatitis (AD) patients across different self-reported racial categories and Fitzpatrick skin types, according to two Phase 3 studies presented at the American Academy of Dermatology’s 2024 meeting in San Diego, CA. Approximately 50% of patients with skin of color were enrolled in ADORING […]